OSI-027 alleviates rapamycin insensitivity by modulation of mTORC2/AKT/TGF-β1 and mTORC1/4E-BP1 signaling in hyperoxia-induced lung injury infant rats

다국어 초록 (Multilingual Abstract)

Background The mechanism of long time and high-concentration oxygen treatment leading to acute lung injury (ALI) or developmental lung disease in infants is currently unclear. Here we found that compared with the effect of rapamycin, pan-mTOR1/2 inhibitor OSI-027, alleviates hyperoxia-induced lung injury (HILI) by modulation of mTORC2/AKT/TGF-β1 and mTORC1/4E-BP1 signaling in infant rats.




Objective Infant rats were treated with continuous inhalation of 90% medical oxygen. Normal saline, rapamycin, or OSI-027 was intraperitoneally injected, and the status of lung injury was tested on days 3, 7, and 14. The activation of mTOR/AKT/TGFβ1 and mTORC1/4E-BP1 signaling was confirmed by immunohistochemistry and Western blot analysis in normal and hyperoxia-treated live precision-cut lung tissues. The inhibitory effect of OSI-027 extended to the active state of other proteins implicated in mTOR1/2 signaling was demonstrated in hyperoxia-induced injured lung tissues.




Results Our data demonstrate that hyperoxia-induced serious lung inflammation and fibrosis. OSI-027 significantly attenuated the pathological process of HILI, inhibit the phosphorylation of the primary downstream targets of mTORC1/C2, and reduce the activation of TGF-β1 signaling.




Conclusions The results suggest that mTORC2/AKT/TGF-β1 and the rapamycin-insensitive mTORC1/4E-BP1 (Thr37/46) signaling has an important effect during HILI with a potential meaning for the progress of novel anti-hyperoxia-injury strategies.

다국어 초록 (Multilingual Abstract)

Background The mechanism of long time and high-concentration oxygen treatment leading to acute lung injury (ALI) or developmental lung disease in infants is currently unclear. Here we found that compared with the effect of rapamycin, pan-mTOR1/2 inhibitor OSI-027, alleviates hyperoxia-induced lung injury (HILI) by modulation of mTORC2/AKT/TGF-β1 and mTORC1/4E-BP1 signaling in infant rats.


Objective Infant rats were treated with continuous inhalation of 90% medical oxygen. Normal saline, rapamycin, or OSI-027 was intraperitoneally injected, and the status of lung injury was tested on days 3, 7, and 14. The activation of mTOR/AKT/TGFβ1 and mTORC1/4E-BP1 signaling was confirmed by immunohistochemistry and Western blot analysis in normal and hyperoxia-treated live precision-cut lung tissues. The inhibitory effect of OSI-027 extended to the active state of other proteins implicated in mTOR1/2 signaling was demonstrated in hyperoxia-induced injured lung tissues.


Results Our data demonstrate that hyperoxia-induced serious lung inflammation and fibrosis. OSI-027 significantly attenuated the pathological process of HILI, inhibit the phosphorylation of the primary downstream targets of mTORC1/C2, and reduce the activation of TGF-β1 signaling.


Conclusions The results suggest that mTORC2/AKT/TGF-β1 and the rapamycin-insensitive mTORC1/4E-BP1 (Thr37/46) signaling has an important effect during HILI with a potential meaning for the progress of novel anti-hyperoxia-injury strategies.

참고문헌 (Reference)

1 Kang SA, "mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycin" 341 : 1236566-, 2013

2 Tian T, "mTOR signaling in cancer and mTOR inhibitors in solid tumor targeting therapy" 20 : 755-, 2019

3 Hu Y, "mTOR and autophagy in regulation of acute lung injury : a review and perspective" 16 : 727-734, 2014

4 Koh HB, "Transforming growth factor-β1 increases DNA methyltransferase 1 and 3a expression through distinct post-transcriptional mechanisms in lung fi broblasts" 291 : 19287-19298, 2016

5 Bahrami A, "Therapeutic potential of targeting PI3K/AKT pathway in treatment of colorectal cancer : rational and progress" 119 : 2460-2469, 2018

6 Özdemir ÖMA, "The eff ects of resveratrol on hyperoxia-induced lung injury in neonatal rats" 55 : 352-357, 2014

7 Özdemir ÖM, "The eff ects of bosentan on hyperoxia-induced lung injury in neonatal rats" 61 : 1120-1126, 2019

8 Wang H, "Targeting mTOR suppressed colon cancer growth through 4EBP1/eIF4E/PUMA pathway" 27 : 448-460, 2020

9 O’Brien NA, "Targeting PI3K/mTOR overcomes resistance to HER2-targeted therapy independent of feedback activation of AKT" 20 : 3507-3520, 2014

10 Bonniaud P, "TGF-beta and Smad3 signaling link infl ammation to chronic fi brogenesis" 175 : 5390-5395, 2005

11 Nadon AM, "Rtp801 suppression of epithelial mTORC1 augments endotoxin-induced lung infl ammation" 184 : 2382-2389, 2014

12 Mitani A, "Restoration of corticosteroid sensitivity in chronic obstructive pulmonary disease by inhibition of mammalian target of rapamycin" 193 : 143-153, 2016

13 Gonzalez-Gonzalez FJ, "Reactive oxygen species as signaling molecules in the development of lung fi brosis" 190 : 61-68, 2017

14 Andreollo NA, "Rat’s age versus human’s age: what is the relationship?" 25 : 49-51, 2012

15 Segura-Ibarra V, "Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension" 524 : 257-267, 2017

16 Zhao B, "Prodomain-growth factor swapping in the structure of pro-TGF-β1" 293 : 1579-1589, 2018

17 Ošt’ádalová I, "Periodization of the early postnatal development in the rat with particular attention to the weaning period" 61 : S1-S7, 2012

18 Vogel ER, "Perinatal oxygen in the developing lung" 93 : 119-127, 2015

19 Yang H, "Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40" 552 : 368-373, 2017

20 Reyburn B, "Mechanisms of injury to the preterm lung and airway : implications for long-term pulmonary outcome" 101 : 345-352, 2012

21 Hsu H-S, "Involvement of ER stress, PI3K/AKT activation, and lung fi broblast proliferation in bleomycin-induced pulmonary fi brosis" 7 : 14272-, 2017

22 Kallet RH, "Hyperoxic acute lung injury" 58 : 123-141, 2013

23 Zaher TE, "Hyperoxia-induced signal transduction pathways in pulmonary epithelial cells" 42 : 897-908, 2007

24 Taha DK, "High fl ow nasal cannula use is associated with increased morbidity and length of hospitalization in extremely low birth weight infants" 173 : 50-55, 2016

25 Dejust S, "Everolimus-induced pulmonary toxicity : fi ndings on 18F-FDG PET/CT imaging" 97 : e12518-, 2018

26 Huang S, "Effect of dual mTOR inhibitor on TGFβ1-induced fibrosis in primary human urethral scar fi broblasts" 106 : 1182-1187, 2018

27 Gupta M, "Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies" 119 : 476-487, 2012

28 Hamdani S, "Delayed and short course of rapamycin prevents organ rejection after allogeneic liver transplantation in rats" 23 : 6962-6972, 2017

29 Dang H-X, "CGRP attenuates hyperoxia-induced oxidative stress-related injury to alveolar epithelial type II cells via the activation of the Sonic hedgehog pathway" 40 : 209-216, 2017

30 Higgins RD, "Bronchopulmonary dysplasia: executive summary of a workshop" 197 : 300-308, 2018

31 Racanelli AC, "Autophagy and inflammation in chronic respiratory disease" 14 : 221-232, 2018

32 Helmerhorst HJF, "Association between arterial hyperoxia and outcome in subsets of critical illness : a systematic review, meta-analysis, and meta-regression of cohort studies" 43 : 1508-1519, 2015